Breast cancerBCCAR T cell therapyMahidol UniversityNational Research Council of ThailandDual BATs
…Background Breast cancer (BC) is the most common cancer among women worldwide and remain…
23,712articles mentioning diseases
125,551disease mentions
18,081distinct diseases extracted
0%of mentions human-reviewed
All extracted diseases
Showing 661–720 of 18,081, ordered by supporting articles. Choose a disease to see its evidence.
retinopathy11Follicular Lymphoma11Haemorrhagic stroke11Hepatitis B virus11Substance use disorder11chronic lymphocytic leukaemia11human cancers11Dural Arteriovenous Fistulas11Gastro-oesophageal reflux disease (GORD)11Haemodynamic instability11Hepatitis C Virus11Inflammatory bowel disease (IBD)11Intracranial atherosclerotic disease (ICAD)11Intracranial atherosclerotic stenosis (ICAS)11acute respiratory failure11Hepatic fibrosis10VF10Macrosomia10Steatosis10JSSc10MCC10Narcolepsy10Miscarriage10irAEs10BAO10CLE10Fragility fractures10Strabismus10CVDs10Restenosis10Self-harm10SA10GCA10Hyponatraemia10PC10SMA10DAVFs10Ischaemia10anal cancer10Encephalitis10MDS10Respiratory failure10Cutaneous Lupus erythematosus10tumor10Ectopic pregnancy10Renal impairment10osteomyelitis10Kawasaki disease10Neurodegenerative Disease10Hyperkalaemia10Hypothermia10Schistosomiasis10neoplasms10Bacteraemia10Fabry disease10Fatty Liver Disease10Glomerulonephritis10Leukemia10Neurological disorders10Wilson’s Disease10
Articles mentioning diseases
23,712 articles · page 432 of 1976colorectal cancerpancreatic cancerPDACCRChuman cancerAZD0240TCR-T cell therapy
…uency, occurring in 28% and 12% of pancreatic cancer (PDAC) and colorectal cancer (CRC), respectively. KRAS G12D-containing peptides are presente…
93.5%
NSCLCmetastatic melanomaStage IV non-small cell lung cancerStage IV melanomaSARS-COV-2 mRNA vaccinesMD Anderson Cancer Center
…ociated with a near doubling of OS among patients with Stage IV NSCLC (555 days vs 1120 days, adj HR 0.5, 95% CI 0.4-0.7) and Stage I…
94.8%
melanomaUniversity of California IrvinenivolumabChao Family Comprehensive Cancer CenteripilimumabPD-1 immunotherapyαPD-1
… approval in 2014 but still fails in the majority of metastatic melanoma patients, emphasizing the need to further understand its impact…
stage IIB/C melanomastage IIB/IIC melanomastage IIB/C diseasestage IIB or IIC melanomaPembrolizumabFDAadjuvant immunotherapy
…, 32% of patients in the US received adjuvant immunotherapy for stage IIB/C melanoma and 21% within our healthcare system. The limited dissemination…
colorectal cancerCRCNivolumabNivoWCG Institutional Review Board
…(Nivo) is an anti-PD-1 immune checkpoint inhibitor approved for colorectal cancer (CRC), yet responses are highly variable between patients, and …
CRCMSS CRCWest China Hospital of Sichuan UniversityAkkInstitutional Review BoardimmunotherapyClinicalTrials.gov
…MSS CRC.Methods Preclinical studies used CT26 mouse models (MSS CRC) with oral Akk administration to assess tumor growth effects. T…
MSS mCRCMSS CRCMSS rectal canceratezolizumabvilastobartXTX101
…lizumab (1200mg Q3W) in heavily pretreated patients (n=44) with MSS mCRC, including 27 with non liver metastases (NLM). In an explorator…
myeloid leukemiaPROCPlatinum resistant ovarian cancerplatinum-resistant ovarian cancerovarian cancerECOG Performance StatusDana-Farber Cancer InstitutePHASE ONE FoundationIL-12IL-15+6 more
…ry-like natural killer cells exhibit enhanced responses against myeloid leukemia. Sci Transl Med. Sep 21 2016;8(357):357ra123. doi:10.1126/scitr…
oral head and neck squamous cell carcinomamelanomathyroid cancersolid tumorsAGX-148Providence Institutional Review BoardClinicalTrials.govlymphodepleting chemotherapy
…bserved in solid tumors including melanoma, thyroid cancer, and oral head and neck squamous cell carcinoma with responses lasting over 600 days in some patients. TCR sequ…
melanomanivolumabRP1Vusolimogene oderparepvecanti-PD-1 therapy
… review, and overall survival (OS) in patients with BRAF-mutant melanoma, stratified by prior BRAFi treatment (data cutoff: March 8, 202…
NeuroblastomaTemozolomideIrinotecandinutuximabaCD40University of Wisconsin
…Background Neuroblastoma is the most common pediatric solid cancer, outside of brain can…